Tafasitamab Treatment Option Approved for Relapsed or Refractory Follicular Lymphoma in US
In June 2025, the U.S. Food and Drug Administration (FDA) approved a new combination treatment option for adults with relapsed or refractory follicular lymphoma (FL).
This combination includes tafasitamab (also known as Monjuvi®, developed by Incyte), rituximab, and lenalidomide — and is now available for eligible patients in the United States.
Upcoming Webinar: FLF Post-ICML Webinar – Charting Our Progress towards a Cure
Join us for an informative webinar where we discuss some of the key topics covered during our Satellite Symposium held in June 2025, at the 18th International Conference of Malignant Lymphoma (ICML) in Lugano.
The Power of Seed Funding: Accelerating Research in Follicular Lymphoma
One example of the impactful ways we advance our mission to cure follicular lymphoma (FL) is through our seed funding of the world-renowned Dana-Farber Cancer Institute.
FLF shines a spotlight on follicular lymphoma at 18-ICML
We are thrilled to announce that the FLF will be taking centre stage at the upcoming 18th International Conference on Malignant Lymphoma (ICML) in Lugano, Switzerland, from June 17th-21st, 2025.
Webinar: When FL Changes: Understanding Progression & Transformation
In this informative webinar, expert clinicians and individuals living with FL came together to explore how to recognise the signs of progression, available treatment options, and what to expect.
FLF’s CMO Shares Key Scientific Highlights from ASH 2024
FLF’s CMO highlights key takeaways from ASH 2024 on follicular lymphoma, from immunotherapy to new treatments.
Webinar: FL and You – Emotional Health & Wellbeing
Watch our recent webinar with a panel of inspiring individuals and expert speakers as they share uplifting personal stories, professional advice and the unique perspective of supporting a loved one with FL.
2024 End of Year Reflections
This year has been transformative, marked by groundbreaking progress in our mission to cure follicular lymphoma.
Unlock the Cure Gala Dinner Raises Over £800,000
We are thrilled to announce that our Unlock the Cure Gala Dinner saw us raise an astounding £800,000 to further our mission of finding a cure for follicular lymphoma.
Our Webinar Series – Register Your Interest
Our webinars are free, interactive, and designed to empower everyone affected by FL. Register today and stay informed on these important discussions.